Editor's overview

Efficacy and safety of ruxolitinib cream for the treatment of vitiligo: week 52 pooled analysis of the TRuE-V phase 3 studies

Rocatinlimab demonstrates improvements in head and neck atopic dermatitis in patients with moderate-severe disease in a phase 2 trial

Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: results from a 2nd phase 3 trial (LIBERTY-PN PRIME)

Efficacy and safety of baricitinib in a Phase 3, randomized, double-blind, placebo-controlled study in pediatric patients with moderate-to-severe Atopic Dermatitis